Patients with severe forms of MS had encouraging results with a autologous hematopoietic stem cell transplantation in a large-scale real-world cohort.

The MS-STAT2 trial of a high-dose simvastatin has failed to slow progression of disability in patients with secondary ...

Secondary imaging endpoints generally were in the same direction as the primary endpoint. Plasma levels of NfL ... in people ...

Should the topline data continue to show a neuroprotective effect and the Phase 2 trial meets its primary and key secondary endpoints, we may also be able to position the drug as the first oral ...

Drugmakers had hoped that inhibiting receptor-interacting protein kinase would decrease inflammation and reduce neuronal degeneration in patients with multiple sclerosis and other neurodegenerative co ...

There are signs that society is moving away from the progressive left’s often strict expectations about how to discuss ...

Primary progressive multiple sclerosis (PPMS) is a type of multiple sclerosis (MS) that gets progressively worse over time. Of the three types of MS, PPMS is considered the rarest, affecting 10% of ...

Ocrevus is the first DMT to ever be approved for primary progressive MS (PPMS). This form of MS is characterized by slowly worsening symptoms and disability from the start of the disease. Relapses may ...

See how we rate auto insurance products to write unbiased product reviews. Founded in 1937, Progressive is known for the TV character "Flo" and its Insurance Superstore commercials. But fame aside ...

and primary progressive multiple sclerosis (PPMS). An electronic version of the Symbol-Digit Modalities Test could enable people with multiple sclerosis (MS) to perform frequent remote cognitive ...

Progressive offers multiple types of insurance, including property coverage for homeowners. You can get a quote through its HomeQuote Explorer tool — the company lets you bundle your home and ...

National Multiple Sclerosis Society: "FDA Approves Ocrevus™ (ocrelizumab) for People with Primary Progressive MS or Relapsing MS -- First Disease-Modifying Therapy for Primary Progressive MS ...